Pentobarbital

Pentobarbital

SCHEMBL2126265

CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.[Na+].c1ccc2ccccc2c1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Pentobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB3 known ✓ P28472 1/20 0.48
GABRA2 known ✓ P47869 1/20 0.48
GABRB2 known ✓ P47870 1/20 0.48
LMNA P02545 4/20 0.49
CYP3A4 P08684 3/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
OPRD1 P41143 1/20 0.48
RECQL P46063 1/20 0.44
MMP9 P14780 1/20 0.37
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
NR1I2 O75469 1/20 0.34
GLA P06280 1/20 0.33
THRB P10828 1/20 0.33
CYP2C9 P11712 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentobarbital SCHEMBL1451667 0.92 CYP3A4 (0.53) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL6822766 0.91 LMNA (0.51) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL22288161 0.91 LMNA (0.42) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL7033991 0.91 CYP3A4 (0.57) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL9221628 0.91 CYP3A4 (0.57) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL1247 0.91 CYP3A4 (0.57) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL15659234 0.90 LMNA (0.50) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL23045802 0.90 CYP3A4 (0.55) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL21634384 0.90 CYP3A4 (0.55) LMNACYP3A4KDM4EALDH1A1GABRB3
Pentobarbital SCHEMBL11559632 0.90 CYP3A4 (0.55) LMNACYP3A4KDM4EALDH1A1GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509433-B2 Process for the production of furfural using a water immiscible organic solvent Covation Inc. (US) 2025-12-30 US disclosed
US-11787773-B2 Process for the production of furfural SHELL USA, INC. (US) 2023-10-17 US disclosed
CN-116715642-A Method for producing furfural using a water-immiscible organic solvent 纳幕尔杜邦公司 2023-09-08 CN disclosed
US-20220259166-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT Covation Inc. 2022-08-18 US disclosed
US-20220227725-A1 PROCESS FOR THE PRODUCTION OF FURFURAL SHELL USA, INC. 2022-07-21 US disclosed
EP-3972962-A1 PROCESS FOR THE PRODUCTION OF FURFURAL Shell Internationale Research Maatschappij B.V. (NL) 2022-03-30 EP disclosed
US-20210070721-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT DUPONT IND BIOSCIENCES USA LLC (US) 2021-03-11 US disclosed
WO-2020234303-A1 PROCESS FOR THE PRODUCTION OF FURFURAL SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2020-11-26 WO disclosed
EP-3725783-A2 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER-IMMISCIBLE ORGANIC SOLVENT E. I. du Pont de Nemours and Company (US) 2020-10-21 EP disclosed
EP-3464256-B1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER-IMMISCIBLE ORGANIC SOLVENT DU PONT (US) 2020-07-29 EP disclosed
US-20200223811-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT DUPONT IND BIOSCIENCES USA LLC (US) 2020-07-16 US disclosed
US-20190284151-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT Dupont Industrial Biosciences USA, LLC. 2019-09-19 US disclosed
EP-3464256-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER-IMMISCIBLE ORGANIC SOLVENT E. I. du Pont de Nemours and Company (US) 2019-04-10 EP disclosed
WO-2017210525-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER-IMMISCIBLE ORGANIC SOLVENT E. I. DU PONT DE NEMOURS AND COMPANY (US) 2017-12-07 WO disclosed
US-20120096878-A1 Refrigeration Circuit and Method for Improving Same SANDEN CORPORATION (JP) 2012-04-26 US disclosed
EP-2444469-A1 REFRIGERATION CIRCUIT AND METHOD FOR IMPROVING SAME Sanden Corporation (JP) 2012-04-25 EP disclosed
EP-0244219-B1 TEMPERATURE HISTORY INDICATOR AND ITS MANUFACTURE MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223811-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT UGDH, C5, FASN GABRB3 4791/4885GABRA2 4739/4885GABRB2 4788/4885
US-20190284151-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT UGDH, C5, FASN GABRB3 4791/4885GABRA2 4739/4885GABRB2 4788/4885
US-20220259166-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT UGDH, C5, FASN GABRB3 4791/4885GABRA2 4739/4885GABRB2 4788/4885
US-20210070721-A1 PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT UGDH, C5, FASN GABRB3 4791/4885GABRA2 4739/4885GABRB2 4788/4885
US-12509433-B2 Process for the production of furfural using a water immiscible organic solvent SORD, PGD, HPD GABRB3 4254/4885GABRA2 4252/4885GABRB2 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.